Leptin-p38MAPK pathway mediates high glucose-induced injury in H9c2 cardiac cells

被引：0
|
作者：
徐文明 [1 ]
机构：
[1] Dept Intern Med,Huangpu Div,1st Affil Hosp, Sun Yat-Sen Univ
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2014年 / 31卷 / 03期
关键词：
MAPK; Leptin-p38MAPK pathway mediates high glucose-induced injury in H9c2 cardiac cells;
D O I：
暂无
中图分类号：
R542.2 [心肌疾病];
学科分类号：
摘要：
Objective To investigate the role of leptin-p38 mitogen-activated protein kinase(MAPK)pathway in high glucose(HG)-induced injury in H9c2 cardiac cells.Methods H9c2 cardiac cells were treated with HG to establish a model of cellular injury induced by HG.Cell viability was tested by cell counter kit 8(CCK-8).The intracellular level of reactive oxygen species(ROS)was
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [1] Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells
    Chen, Jingfu
    Mo, Hailiang
    Guo, Runmin
    You, Qiong
    Huang, Ruina
    Wu, Keng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (03) : 605 - 612
  • [2] Inhibition of P38 MAPK Pathway Contributes to the Protection of Edaravone Against High Glucose-Induced Insult in H9c2 Cardiac Cells
    Xu Wen-Ming
    Zhang Chang-Ran
    Guo Run-Min
    Feng Jian-Qiang
    DIABETES, 2013, 62 : A604 - A604
  • [3] Naringin Inhibits ROS-activated MAPK Pathway in High Glucose-induced Injuries in H9c2 Cardiac Cells
    Chen, Jingfu
    Guo, Runmin
    Yan, Hai
    Tian, Lihong
    You, Qiong
    Li, Shanghai
    Huang, Ruina
    Wu, Keng
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 114 (04) : 293 - 304
  • [4] Hydrogen Sulfide Protects H9c2 Cardiac Cells Against High Glucose-Induced Injury Through Inhibiting JNK Pathway
    Wen-Ming, Xu
    Jian-Cong, Lin
    Jian-Qiang, Feng
    DIABETES, 2013, 62 : A604 - A604
  • [5] Exogenous hydrogen sulfide ameliorates high glucose-induced myocardial injury & inflammation via the CIRP-MAPK signaling pathway in H9c2 cardiac cells
    Zhao, Hong-Lei
    Wu, Bao-Quan
    Luo, Ying
    Zhang, Wen-Ying
    Hao, Yun-Ling
    Liang, Jin-Jie
    Fang, Fang
    Liu, Wei
    Chen, Xie-Hui
    LIFE SCIENCES, 2018, 208 : 315 - 324
  • [6] Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways
    Xu, Wenming
    Wu, Wen
    Chen, Jingfu
    Guo, Runmin
    Lin, Jiancong
    Liao, Xinxue
    Feng, Jianqiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 (04) : 917 - 925
  • [7] Interleukin-33 prevents high glucose-induced apoptosis in H9c2 cardiac cells by inhibiting reaction oxygen species-activated JNK and p38 MAPK pathway
    Liu, Dan
    Mao, Tuohua
    Lv, Xifeng
    Tang, Qizhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 10497 - 10504
  • [8] Simvastatin protects high glucose-induced H9c2 cells from injury by inducing autophagy
    Lusha, E.
    Jiang, Hong
    PHARMACEUTICAL BIOLOGY, 2020, 58 (01) : 1077 - 1084
  • [9] Naringin attenuates high glucose-induced injuries and inflammation by modulating the leptin-JAK2/STAT3 pathway in H9c2 cardiac cells
    Luo, Changjun
    Ke, Xiao
    Xiong, Si
    Sun, Yun
    Xu, Qing
    Zhang, Wei
    Lei, Yiyan
    Ding, Yiqian
    Zhen, Yulan
    Feng, Jianqiang
    Cheng, Fei
    Chen, Jingfu
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (05) : 1145 - 1157
  • [10] Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells
    Asadi, Firouzeh
    Razmi, Ali
    Dehpour, Ahmad Reza
    Shafiei, Massoumeh
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (04) : 485 - 493
12345